rs141560438
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_020919.4(ALS2):c.2841+48delT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0457 in 1,609,216 control chromosomes in the GnomAD database, including 1,885 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.034 ( 112 hom., cov: 31)
Exomes 𝑓: 0.047 ( 1773 hom. )
Consequence
ALS2
NM_020919.4 intron
NM_020919.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.954
Genes affected
ALS2 (HGNC:443): (alsin Rho guanine nucleotide exchange factor ALS2) The protein encoded by this gene contains an ATS1/RCC1-like domain, a RhoGEF domain, and a vacuolar protein sorting 9 (VPS9) domain, all of which are guanine-nucleotide exchange factors that activate members of the Ras superfamily of GTPases. The protein functions as a guanine nucleotide exchange factor for the small GTPase RAB5. The protein localizes with RAB5 on early endosomal compartments, and functions as a modulator for endosomal dynamics. Mutations in this gene result in several forms of juvenile lateral sclerosis and infantile-onset ascending spastic paralysis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 2-201728463-TA-T is Benign according to our data. Variant chr2-201728463-TA-T is described in ClinVar as [Likely_benign]. Clinvar id is 261371.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0506 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0344 AC: 5235AN: 152148Hom.: 112 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
5235
AN:
152148
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0392 AC: 9758AN: 249202 AF XY: 0.0415 show subpopulations
GnomAD2 exomes
AF:
AC:
9758
AN:
249202
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0469 AC: 68278AN: 1456950Hom.: 1773 Cov.: 29 AF XY: 0.0473 AC XY: 34336AN XY: 725236 show subpopulations
GnomAD4 exome
AF:
AC:
68278
AN:
1456950
Hom.:
Cov.:
29
AF XY:
AC XY:
34336
AN XY:
725236
Gnomad4 AFR exome
AF:
AC:
375
AN:
33380
Gnomad4 AMR exome
AF:
AC:
1233
AN:
44716
Gnomad4 ASJ exome
AF:
AC:
949
AN:
26110
Gnomad4 EAS exome
AF:
AC:
317
AN:
39646
Gnomad4 SAS exome
AF:
AC:
4232
AN:
86130
Gnomad4 FIN exome
AF:
AC:
1823
AN:
53334
Gnomad4 NFE exome
AF:
AC:
56386
AN:
1107666
Gnomad4 Remaining exome
AF:
AC:
2731
AN:
60214
Heterozygous variant carriers
0
3107
6213
9320
12426
15533
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
2074
4148
6222
8296
10370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0344 AC: 5236AN: 152266Hom.: 112 Cov.: 31 AF XY: 0.0330 AC XY: 2456AN XY: 74430 show subpopulations
GnomAD4 genome
AF:
AC:
5236
AN:
152266
Hom.:
Cov.:
31
AF XY:
AC XY:
2456
AN XY:
74430
Gnomad4 AFR
AF:
AC:
0.0128242
AN:
0.0128242
Gnomad4 AMR
AF:
AC:
0.031495
AN:
0.031495
Gnomad4 ASJ
AF:
AC:
0.033468
AN:
0.033468
Gnomad4 EAS
AF:
AC:
0.0125483
AN:
0.0125483
Gnomad4 SAS
AF:
AC:
0.0408883
AN:
0.0408883
Gnomad4 FIN
AF:
AC:
0.0313737
AN:
0.0313737
Gnomad4 NFE
AF:
AC:
0.0501176
AN:
0.0501176
Gnomad4 OTH
AF:
AC:
0.0382798
AN:
0.0382798
Heterozygous variant carriers
0
254
508
763
1017
1271
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
81
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Aug 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at